ClinicalTrials.gg
CompletedNCT05138965Updated Mar 18, 2024

the Method of Cotton Padding Promoting the Rectovaginal Fistula Surgery

An observational study in Healing of the Wound After Rectovaginal Fistula Surgery, sponsored by China Academy of Chinese Medical Sciences. Completed at 3 sites in China. Open to female participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2024-03-18.

Sponsored by China Academy of Chinese Medical Sciences · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
20
Ages
18 Years to 60 Years
Sex
Female
01

Study summary

The method of Cotton Padding (mCP) was summarized by combining with many years clinical experience and the traditional ancient books.The mCP could be used in Rectovaginal Fistula (RVF) post operation effectively,in order to improve the wound.The research aim is to observe if the mCP could influence the time of staying in hospital, healing time after RVF surgery.

Read the detailed description

The method of Cotton Padding (mCP) originating from extensive and profound traditional chinese medicine (TCM) and being one of traditional surgical treatments of chronic wounds,could promote the wound healing after RVF surgery in previous clinical experience.

The research aim is to observe if the mCP could influence the time of staying in hospital, healing time,quality of life,complications after RVF surgery.

Also,investigators will try to explain the mechanism about the mDM improving the wound healing by the chinese architectural theory and the nanomechanical properties.

02

Conditions studied

  • Healing of the Wound After Rectovaginal Fistula Surgery

Keywords

  • Rectovaginal Fistula
  • Healing
  • Cotton Padding
03

In context

Lead sponsor

China Academy of Chinese Medical Sciences is the lead sponsor of 62 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Rectovaginal fistulae are rare and account for less than 5% of all anorectal fistulae[1,2].

The most common cause of RVF is obstetric trauma[2]. Trauma to the rectum, perineum,or vagina may cause RVF.The commonest form of trauma is during or following surgery, although blunt or penetrating trauma to the perineum or use of a foreign body in the vagina or rectum are well-recognized causes.The use of surgical stapling devices during stapled hemorrhoidectomy and stapled transanal rectal resections (STARR) have been implicated.

(© Springer Nature Switzerland AG 2021. G.A.Santoro et al. (eds.), Pelvic Floor Disorders, https://doi.org/10.1007/978-3-030-40862-6_79)

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • rectovaginal fistula because of parturition,stapler,traumatic injury.

Exclusion criteria

Exclusion Criteria:

  • rectovaginal fistula because of IBD,radiation,cancer.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
20 participants (actual)
Patient registry
No

Groups and cohorts

  • using the mCP

    When the secretion reducing or the wound suture being removed, two pieces of 5cm×7cm-12p sterile gauzes will be crimped by the long side as the center of the reel,and be made as cylindrical gauze rolls with about D=1.5cm. After cleaning the wound, the cylindrical gauze rolls with its surface covered by alginates dressing will be placed above the vaginal wound with the help of endoscope.Itself tension of the rolls pressuring on the wound and the deep tissue can promote the wound healing. The rolls will be placed on about 5-6 hours every time, 2 times a day, for 7 days.Then observing the wound, if necessary, the method will be executed for another 7 days.

    Procedure: the mCP with alginates dressing

  • no using the mCP

    When the secretion reducing or the wound suture bing removed, only alginates dressing will be placed above the vaginal wound with the help of endoscope, without any pressure, being placed about 5-6 hours every time, 2 times a day, for 7 days.

    Procedure: only alginates dressing

Interventions

  • Procedurethe mCP with alginates dressing

    The method is to use gauzes folded onto the RVF wound surface to compact the deep wound so as to solid and durable,when the gauzes surface will be covered by alginates dressing.

    Also known as: the method of cotton padding with alginates dressing

  • Procedureonly alginates dressing

    Only alginates dressing will be placed above the RVF wound without any pressure.

    Also known as: only alginates dressing without the mCP

06

What researchers measure

Primary outcomes

  1. the time of healing

    the time of healing

    Time frame: 28days-40days

Secondary outcomes

  1. the time of staying hospital

    the time of staying hospital

    Time frame: 7days-21days

  2. occurrence rate of complications

    occurrence rate of complications,including recurrence,blooding,wound dehiscence.

    Time frame: 1day-90days

Other outcomes

  1. the quality of life post-operation

    using the Wexner continence score (WCS) or the Vaizey score (VS) to assess the fecal incontinence,and using the Female sexual function index (FSFI) to assess the sex life,and aslo using the Clavien-Dindo classification(CDC) to assess other situation postoperatively.

    Time frame: 90days-180days

07

Study locations

3 sites
  • Guang'anmen Hospital of China Academy of Chinese Medical Sciences
    Beijing, 100053, China
  • Beijing Mayinglong Changqing Anorectal Hospital
    Beijing, 100195, China
  • Southern District of Guang'an men Hospital,China Academy of Chinese Medical Sciences
    Beijing, 102618, China
08

References and documents

Individual participant data

Plan to share: Yes — Individual participant data that underline the results reported in the article after identification, excluding the private information of participants.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

Time frame: Becoming available after publication and ending 12 months following article publication.

Access criteria: Proposals should be emailed to venus59514@sina.com.To gain access, data requestors will need to sign a data access agreement and offer payment.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 18, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05138965
Lead sponsor
China Academy of Chinese Medical Sciences
Responsible party
FENG Li-peng (Attending Doctor, China Academy of Chinese Medical Sciences) — Principal investigator
First posted
Dec 1, 2021
Start date
Jan 10, 2022
Primary completion
Mar 15, 2024
Completion
Mar 15, 2024
Last update
Mar 18, 2024

Study contacts

LI guodong
study director · Guang'anmen Hospital of China Academy of Chinese Medical Sciences

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion